Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non-Current Liabilities: 2020-2022

Historic Other Non-Current Liabilities for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $1.1 million.

  • Terns Pharmaceuticals' Other Non-Current Liabilities rose 56.84% to $1.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.1 million, marking a year-over-year increase of 56.84%. This contributed to the annual value of $1.1 million for FY2022, which is 36.09% up from last year.
  • Terns Pharmaceuticals' Other Non-Current Liabilities amounted to $1.1 million in FY2022, which was up 36.09% from $787,000 recorded in FY2021.
  • Terns Pharmaceuticals' Other Non-Current Liabilities' 5-year high stood at $1.1 million during FY2022, with a 5-year trough of $657,000 in FY2020.
  • In the last 3 years, Terns Pharmaceuticals' Other Non-Current Liabilities had a median value of $787,000 in 2021 and averaged $838,333.
  • Data for Terns Pharmaceuticals' Other Non-Current Liabilities shows a peak YoY skyrocketed of 36.09% (in 2022) over the last 5 years.
  • Over the past 3 years, Terns Pharmaceuticals' Other Non-Current Liabilities (Yearly) stood at $657,000 in 2020, then rose by 19.79% to $787,000 in 2021, then spiked by 36.09% to $1.1 million in 2022.